Stacie Lindsey
@staclinds
CEO and Founder of the Cholangiocarcinoma Foundation, mother of 5, happily married.
ID:2281607719
http://cholangiocarcinoma.org 08-01-2014 04:54:41
1,0K Tweets
591 Followers
772 Following
NCI Center for Cancer Research - Dr. Tim Greten receives 2024 Innovation Grant from the Cholangiocarcinoma Foundation!
NCI Center for Cancer Research
oncodaily.com/60948.html
#Cancer #Cholangiocarcinoma #GastrointestinalCancer #ClinicalTrials #Cancer Research #NCI #OncoDaily #Oncology
CtDNA based MRD detection correlates with outcomes in resected biliary tract cancers patients- A RWE study. The evidence is building up in BTC and continues to grow in GI cancers. Cholangiocarcinoma Foundation #ccf2024 Stacie Lindsey Melinda Bachini
ICYMI: Dr. Thomas Schuetz, President of R&D at Compass Therapeutics, discussed the Investigational Drug CTX-009 and the Phase 2/3 Biliary Tract Cancer Clinical Trial with Mitesh Borad, M.D. from Mayo Clinic.
You can catch the recording on our YouTube channel now๐๐ผ youtube.com/watch?v=jiMqh0โฆ.
Feel reinvigorated Cholangiocarcinoma Foundation #CCF2024 connecting with colleagues, friends, patients and caregivers. #endcancer ๐
Please join me & Cancer Precision Medicine Commons for a webinar on May 22 on best practices & recommendations for developing patient education resources for #BioMarkerTesting & #GeneticTesting for inherited cancer risk. Register at curecca.link/CPM.
Grateful to the scientific community, Stacie Lindsey, Juan Valle, and a wonderful co-chair Daniela Sia for making the first Basic Science Track at Cholangiocarcinoma Foundation Annual Conference a huge success. We had remarkable speakers from all over the world in a packed room with robust discussion.
#Research is #Hope and how we are moving #forward . There are many ongoing #TrialsInProgress presented at #ccfac24 . Part 1/2
Mitesh Borad, M.D. Angela Lamarca
A tour de force State-of-the-art lecture by Tim Greten at Cholangiocarcinoma Foundation basic science track - From Mice to Men and Back to Mice: Basic and Translational Research Studies in CCA. Highlighting the importance of using the right preclinical models + patient data in a complementary manner.
Starting the inaugural basic science track Cholangiocarcinoma Foundation a real pleasure to be part of this exciting group of researchers. #cholangiocarcinoma
Always great to partner with Cholangiocarcinoma Foundation for
AHPBA combined symposium on
#cholangiocarcinoma #AHPBA2024 ๐